Replies to post #26749 on Biotech Values

[DewDiligence]

>[RHEO] I'm still puzzled how the company's value is 3.5 times their cash holding.<

There are evidently a lot of suckers out there who want to own “the best biotech company no one has heard of” (Jim Cramer’s words).

[DewDiligence]

LOL re RHEO (one of my perpetual pans):

http://biz.yahoo.com/iw/060508/0127784.html

RHEO booked zero sales in 1Q06 because docs in Canada stopped advising patients to get rheopheresis treatments three months ago when the phase-3 trial in dry AMD showed no statsig benefit relative to placebo. The CEO today said the falloff in procedures was only temporary. I guess you gotta admire the chutzpah.